scopolamine drug
Evidence from:
primary |
all sources
Related entities (7)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| scopolamine | associated_with | attention network | — | 1 |
| scopolamine | targets | CHRM2 | — | 1 |
| scopolamine | regulates | dopamine efflux | — | 1 |
| scopolamine | protective_against | drug-seeking behavior | — | 1 |
| scopolamine | interacts_with | LDTg | — | 1 |
| scopolamine | regulates | memory | — | 1 |
| scopolamine | interacts_with | VTA | — | 1 |
Mentioned in (8)
Papers in which this entity is mentioned.
- Cotinine: Pharmacologically Active Metabolite of Nicotine and Neural Mechanisms for Its Actions. (2021)
- In utero exposure to HIV and/or antiretroviral therapy: a systematic review of preclinical and clinical evidence of cognitive outcomes. (2019)
- Theta-gamma coupling in the entorhinal-hippocampal system. (2015)
- Modulation of pilocarpine-induced seizures by cannabinoid receptor 1. (2014)
- Acetylcholine as a neuromodulator: cholinergic signaling shapes nervous system function and behavior. (2012)
- Early pharmacotherapy restores neurogenesis and cognitive performance in the Ts65Dn mouse model for Down syndrome. (2010)
- Muscarinic type 2 receptors in the lateral dorsal tegmental area modulate cocaine and food seeking behavior in rats. (2010)
- Trace eyeblink conditioning increases CA1 excitability in a transient and learning-specific manner. (1996)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| scopolamine | drug | 7 | 17 |
| muscarinic antagonist | drug | 1 | 1 |